Vorobioff J, Picabea E, Villavicencio R, Puccini V, Rossi O, Bordato J, Audano M
Hepatology. 1987 Jul-Aug;7(4):648-53. doi: 10.1002/hep.1840070406.
Different and contradictory results concerning the use of propranolol in the treatment of portal hypertension have been reported. This study was designed to investigate the hemodynamic effects of short- and long-term administration of propranolol in portal hypertensive patients. Portal pressure, cardiac index, heart rate and blood pressure were obtained in 18 unselected alcoholic cirrhotic patients with esophageal varices before and 60 min after the oral administration of 40 mg propranolol and again after 106 +/- 35 days of continuous oral administration (mean dose = 158 +/- 63 mg per day). Baseline portal pressure was 21.7 +/- 7.2 mm Hg. It decreased after 60 min to 17.2 +/- 5.5 mm Hg (p less than 0.01) and after long-term administration of propranolol to 16.1 +/- 5.7 mm Hg (p less than 0.01). No decrease in portal pressure was noted in 9 of 18 (50%) patients after acute administration and 5 of 17 (30%) patients after long-term administration. Baseline cardiac index was 5.1 +/- 1.2 liters X min-1 X m-2. It decreased after 60 min to 3.9 +/- 1.4 liters X min-1 X m-2 (p less than 0.01) and to 3.6 +/- 1.0 liters X min-1 X m-2 after long-term administration (p less than 0.001). Baseline heart rate was 85 +/- 11 beats per min. It decreased after 60 min to 75 +/- 9 (p less than 0.001) and after long-term administration to 62 +/- 6 (p less than 0.001) beats per min. Baseline mean arterial pressure was 108 +/- 11 Hg. It decreased after 60 min to 97 +/- 14 mm Hg (p less than 0.01) and after long-term administration to 103 +/- 14 mm Hg (not statistically significant).(ABSTRACT TRUNCATED AT 250 WORDS)
关于使用普萘洛尔治疗门静脉高压症,已有不同且相互矛盾的结果报道。本研究旨在调查门静脉高压症患者短期和长期服用普萘洛尔后的血流动力学效应。对18例未经挑选的伴有食管静脉曲张的酒精性肝硬化患者,在口服40毫克普萘洛尔前及服药后60分钟,以及连续口服(平均剂量 = 每天158±63毫克)106±35天后,分别测量门静脉压力、心脏指数、心率和血压。基线门静脉压力为21.7±7.2毫米汞柱。60分钟后降至17.2±5.5毫米汞柱(p<0.01),长期服用普萘洛尔后降至16.1±5.7毫米汞柱(p<0.01)。18例患者中有9例(50%)急性给药后门静脉压力未降低,17例患者中有5例(30%)长期给药后未降低。基线心脏指数为5.1±1.2升·分钟⁻¹·米⁻²。60分钟后降至3.9±1.4升·分钟⁻¹·米⁻²(p<0.01),长期给药后降至3.6±1.0升·分钟⁻¹·米⁻²(p<0.001)。基线心率为每分钟85±11次。60分钟后降至每分钟75±9次(p<0.001),长期给药后降至每分钟62±6次(p<0.001)。基线平均动脉压为108±11毫米汞柱。60分钟后降至97±14毫米汞柱(p<0.01),长期给药后降至103±14毫米汞柱(无统计学意义)。(摘要截选至250字)